Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
A J Conde-MorenoJ Expósito-Hernández

Abstract

Data in the literature support the existence of a state of limited metastases or oligometastases. Favorable outcomes have been observed in selected patients with such oligometastases that are treated with local ablative therapies, which include surgical extirpation, stereotactic body radiation therapy (SBRT), and radiofrequency ablation. The role of SBRT in the setting of lymph node oligometastases is still emerging but the early results for local control are promising. However, the biggest challenge is to identify patients who will benefit from treatment of their oligometastatic disease with local aggressive therapy. Patients are initially categorized based upon examination of the initial biopsy, location, stage, and previous treatments received. Appropriate patient management with SBRT requires an understanding of several clinicopathological features that help to identify several subsets of patients with more responsive tumors and a good tolerance to SBRT. In an effort to incorporate the most recent evidence, here the Spanish Society of Radiation Oncology presents guidelines for using SBRT in lymph node oligometastases.

References

Feb 22, 1990·The New England Journal of Medicine·R A PatchellB Young
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Hellman, R R Weichselbaum
Jan 1, 1997·The Journal of Thoracic and Cardiovascular Surgery·U PastorinoUNKNOWN International Registry of Lung Metastases
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y FongM F Brennan
Nov 19, 2003·Japanese Journal of Clinical Oncology·Joon Oh ParkKeunchil Park
Sep 20, 2006·Acta Oncologica·Morten HoyerHans Von der Maase
Jun 11, 2008·Abdominal Imaging·Min Jung ParkByung-Tae Kim
Nov 8, 2008·International Journal of Radiation Oncology, Biology, Physics·Chul Won ChoiBeob Jong Kim
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jun 24, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Richard L WahlMartin A Lodge
May 5, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Barbara A Jereczek-FossaRoberto Orecchia
Aug 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Barbara WysockaJolie Ringash
Dec 23, 2009·World Journal of Gastroenterology : WJG·Mi-Sook KimYoung Joo Shin
Jan 6, 2010·Japanese Journal of Clinical Oncology·Yuzuru Niibe, Kazushige Hayakawa
Apr 8, 2010·Clinical & Experimental Metastasis·Jin-Kyu KangUi-Sup Shin
Jun 1, 2010·International Journal of Radiation Oncology, Biology, Physics·Carlo GrecoYoshiya Yamada
Aug 31, 2010·International Journal of Radiation Oncology, Biology, Physics·Mario BignardiMarta Scorsetti
Oct 1, 2010·Medical Physics·Stanley H BenedictFang-Fang Yin
Feb 1, 2011·International Journal of Radiation Oncology, Biology, Physics·Barbara Alicja Jereczek-FossaRoberto Orecchia
Jan 3, 2012·International Journal of Radiation Oncology, Biology, Physics·Sun Hyun BaeByung Chul Yoo
Jan 14, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jose L Lopez GuerraZhongxing Liao
Feb 3, 2012·Journal of Surgical Oncology·Sun Hyun BaeDong Han Lee
Aug 3, 2012·Radiation Oncology·Mohammed Yahia AlmaghrabiEmmanuel Rio
Oct 20, 2012·International Journal of Radiation Oncology, Biology, Physics·Sun Hyun BaeSang Bum Kim
Nov 13, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C V SoleH Marsiglia
Apr 6, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mohsen BeheshtiWolfgang Loidl
Sep 28, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Ali Afshar-OromiehUwe Haberkorn
Dec 10, 2013·Critical Reviews in Oncology/hematology·Berardino De BariBarbara Alicja Jereczek-Fossa
Apr 24, 2014·BioMed Research International·Valeria PanebiancoVincenzo Tombolini
May 21, 2014·Cancer Epidemiology·Yvette R B M van GestelValery E P P Lemmens
Jun 13, 2014·Radiation Oncology·Karel DecaesteckerPiet Ost
Aug 12, 2014·European Urology·Giorgio GandagliaMaxine Sun
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph K Salama, Michael T Milano
Oct 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Puneeth IyengarRobert Timmerman
Mar 21, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Matthias EiberMarkus Schwaiger
Dec 24, 2015·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Barbara Alicja Jereczek-FossaRoberto Orecchia

❮ Previous
Next ❯

Citations

Mar 1, 2019·World Journal of Clinical Oncology·Amalia Palacios-EitoSonia García-Cabezas
Oct 26, 2018·Technology in Cancer Research & Treatment·Haruo MatsushitaNoriyuki Kadoya

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved